Toshihiko Komai

机构：The University of Tokyo · ORCID：0000-0001-5890-3606

发表论文 92 篇 · 总被引 1427 次 · h-index 18

代表论文

• Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches (2025 · International Journal of Molecular Sciences · 被引 38)
• Egr2 drives the differentiation of Ly6Chi monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice (2024 · Communications Biology · 被引 19)
• Clinical Characteristics of Cryopyrin‐Associated Periodic Syndrome and Long‐Term Real‐World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey (2024 · Arthritis & Rheumatology · 被引 15)
• A diagnostic score for eosinophilic granulomatosis with polyangiitis among eosinophilic disorders (2022 · Allergology International · 被引 12)
• Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy (2022 · Rheumatology International · 被引 11)
• Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation (2022 · Clinical Rheumatology · 被引 11)